Andrew Reardon - Aug 10, 2023 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
CHIEF LEGAL OFFICER &
Signature
/s/ Andrew Reardon
Stock symbol
LGND
Transactions as of
Aug 10, 2023
Transactions value $
-$61,651
Form type
4
Date filed
8/14/2023, 04:20 PM
Previous filing
Mar 28, 2023
Next filing
Jan 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Tax liability -$61.7K -897 -5.5% $68.73 15.4K Aug 10, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.